Literature DB >> 18664458

Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP.

Bastian Linder1, Oliver Plöttner, Matthias Kroiss, Enno Hartmann, Bernhard Laggerbauer, Gunter Meister, Eva Keidel, Utz Fischer.   

Abstract

Tudor domains are widespread among proteins involved in RNA metabolism, but only in a few cases their cellular function has been analyzed in detail. Here, we report on the characterization of the ubiquitously expressed Tudor domain containing protein Tdrd3. Apart from its Tudor domain, we show that Tdrd3 possesses an oligosaccharide/nucleotide binding fold (OB-fold) and an ubiquitin associated domain capable of binding tetra-ubiquitin. A set of biochemical experiments revealed an interaction of Tdrd3 with FMRP, the product of the gene affected in Fragile X syndrome, and its autosomal homologs FXR1 and FXR2. FMRP has been implicated in the translational regulation of target mRNAs and shown to be a component of stress granules (SG). We demonstrate that overexpression of Tdrd3 in cells induces the formation of SGs and as a result leads to its co-localization with endogenous FMRP in these structures. Interestingly, the disease-associated FMRP missense mutation I304N identified in a Fragile X patient severely impairs the interaction with Tdrd3 in biochemical experiments. We propose a contribution of Tdrd3 to FMRP-mediated translational repression and suggest that the loss of the FMRP-Tdrd3 interaction caused by the I304N mutation might contribute to the pathogenesis of Fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664458     DOI: 10.1093/hmg/ddn219

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  TDRD3 is an effector molecule for arginine-methylated histone marks.

Authors:  Yanzhong Yang; Yue Lu; Alexsandra Espejo; Jiacai Wu; Wei Xu; Shoudan Liang; Mark T Bedford
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

2.  Metazoan stress granule assembly is mediated by P-eIF2alpha-dependent and -independent mechanisms.

Authors:  Natalie G Farny; Nancy L Kedersha; Pamela A Silver
Journal:  RNA       Date:  2009-08-06       Impact factor: 4.942

3.  Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation.

Authors:  Yanzhong Yang; Kevin M McBride; Sean Hensley; Yue Lu; Frederic Chedin; Mark T Bedford
Journal:  Mol Cell       Date:  2014-02-06       Impact factor: 17.970

4.  A stimulatory role for the La-related protein 4B in translation.

Authors:  Katrin Schäffler; Kristina Schulz; Anja Hirmer; Julia Wiesner; Michael Grimm; Albert Sickmann; Utz Fischer
Journal:  RNA       Date:  2010-06-23       Impact factor: 4.942

Review 5.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

6.  Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly.

Authors:  Wei-Chih Tsai; Sitaram Gayatri; Lucas C Reineke; Gianluca Sbardella; Mark T Bedford; Richard E Lloyd
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

7.  DNA and RNA topoisomerase activities of Top3β are promoted by mediator protein Tudor domain-containing protein 3.

Authors:  Grace Ee-Lu Siaw; I-Fen Liu; Po-Yen Lin; Michael D Been; Tao-Shih Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-31       Impact factor: 11.205

8.  Molecular Evolution of DNA Topoisomerase III Beta (TOP3B) in Metazoa.

Authors:  Filipa Moreira; Miguel Arenas; Arnaldo Videira; Filipe Pereira
Journal:  J Mol Evol       Date:  2021-05-17       Impact factor: 2.395

Review 9.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

Review 10.  Translating nociceptor sensitivity: the role of axonal protein synthesis in nociceptor physiology.

Authors:  Theodore J Price; Sandrine M Géranton
Journal:  Eur J Neurosci       Date:  2009-05-29       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.